DaVita Inc.
Market cap $15.1B
$235.44
DVA
$235.44
+0.50% today
Buy with €1M virtual cash · No real money
DaVita Inc. (DVA) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates DVA a Buy, with the stock up 56% over the past year. You can practice trading DVA risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$15.1B
Volume
535K
52-wk High
$239.64
52-wk Low
$101.00
Day High
$237.85
Day Low
$231.20
P/E (TTM)
21.98
Revenue (TTM)
$13.8B
EPS (TTM)
$10.71
Performance
1M
+10.5%
6M
+115.7%
1Y
+55.6%
Invest signal · DVA
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
DVA overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev -5.6%Revenue
$3BEPS (diluted)
$2.87 per shareLatest DVA news
Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026.
The Motley Fool · Jul 9
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't
The Motley Fool · Jun 3
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
Benzinga · May 6
Heart Risks Go Beyond the Heart: Don’t Forget to Check Blood Sugar and Kidney Health
GlobeNewswire Inc. · Mar 30
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
GlobeNewswire Inc. · Mar 17
About DaVita Inc.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement.
DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Employees
78,000
30-Day Win Rate · DVA
16 days
7 days
Last 23 sessions
How to practice trading DVA
- 1
Use the DVA buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top DVA traders on Invest
Full leaderboardFrequently asked questions
Is DVA a good stock to buy right now?
As of July 27, 2026, Invest's signal rates DVA a Buy, based on its price trend, valuation, and fundamentals (P/E around 22.0), with the stock up 56% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading DVA risk-free first.
What is DaVita Inc.'s (DVA) market cap?
DaVita Inc. has a market capitalization of approximately $15.1B, on trailing-twelve-month revenue of about $13.8B.
How has DVA stock performed?
DVA is up 56% over the past year and up 116% over six months. Its 52-week range runs roughly from $101.00 to $239.64. Past performance doesn't predict future results.
How can I practice trading DVA for free?
On Invest you get €1,000,000 in virtual cash and can buy DVA at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare DVA with peers